Recently published papers: Pseudomonas, brain and bowel injury and novel cardiac therapies.
Ventilator-associated pneumonia is a familiar foe in intensive care units, but those associated with Pseudomonas aeruginosa have a particularly adverse impact on outcome. Correct antibiotic therapy and a novel endotracheal tube may reduce this burden. Does activated protein C improve outcome from acute lung injury and what is the role played by hyperventilation therapy in traumatic brain injury? Recent research has attempted to answer these questions. Further novel approaches have been evaluated in the management of ischaemic heart disease, and more light has been shed on acute bowel injury.
Bandarupalli
Uma M
UM
University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester LE1 5WW, UK.
Williams
Gareth
G
D001930:Brain Injuries / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D006801:Humans; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development
D002317:Cardiovascular Agents